Prime Therapeutics announces Mostafa Kamal as president

by DailyBriefers
0 comment

EAGAN, Minn., March 27, 2023 /PRNewswire/ — Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, has appointed Mostafa Kamal as president of the organization. Kamal also serves as CEO of Magellan Rx, a company that was acquired by Prime in December 2022. Ken Paulus, CEO of Prime, will continue in his current position.

You may also like

Leave a Comment